How do patients prefer specialized clinical pharmacy service to other prevention of mother-to-child transmission of human immunodeficiency virus services? An evaluation of their willingness to pay and willingness to accept choices and ratios.
AbdulMuminu IsahMaxwell Ogochukwu AdibeAbubakar AbbaObinna Felix DimAzubuike Amos EkwuofuHadiza Usman Ma'ajiChinwe Victoria UkwePatrick Obinna UdeogaranyaMathew Jegbefume OkontaPublished in: Journal of clinical pharmacy and therapeutics (2021)
Most patients assessed in this study were willing to pay for PPV than other services. Majority of them were also willing to forgo PMTCT Drugs Only. SCPS had the highest value for the patients, but they did not want to pay a high amount for it. Employment status, health insurance status, educational level and age were predictors of patients' WTP and WTA.
Keyphrases
- end stage renal disease
- health insurance
- ejection fraction
- human immunodeficiency virus
- newly diagnosed
- chronic kidney disease
- healthcare
- mental health
- peritoneal dialysis
- prognostic factors
- primary care
- hepatitis c virus
- palliative care
- patient reported outcomes
- hiv infected
- patient reported
- antiretroviral therapy
- hiv aids
- hiv positive
- mental illness